In 2022, the global market for atherectomy and Intravascular Lithotripsy devices reached a valuation of more than $801 million. It is projected to grow at a compound annual growth rate (CAGR) of 6.1% during the forecast period, surpassing $1.2 billion.
The market includes laser atherectomy, mechanical atherectomy, and IVL devices, and it is analyzed as a single entity without further segmentation.
The market for coronary atherectomy is expected to be limited by the efficacy of drug-eluting stents (DESs). The use of DESs provides cardiologists with a sense of confidence in preventing restenosis, potentially leading them to be less cautious in preparing the lesion before stent deployment. As the utilization of DESs becomes more prevalent in coronary procedures, the demand for atherectomy devices is likely to decline.
ShockWave Medical, as the leading competitor, specializes in IVL technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. Their device, ShockWave C2, has established a strong market presence.
Boston Scientific, the second-leading competitor, focuses on the mechanical atherectomy device market. While they continue to maintain competitiveness in this segment, they have experienced a decline in market share in recent years.
Cardiovascular Systems, Inc. (CSI) held the third-leading position in the coronary atherectomy device market. Their presence in the overall market was primarily attributed to their involvement in the mechanical atherectomy device segment, where they held a significant share.
Overall, these three competitors played a crucial role in shaping the atherectomy and IVL device market landscape in 2022.
The market includes laser atherectomy, mechanical atherectomy, and IVL devices, and it is analyzed as a single entity without further segmentation.
ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Coronary and Peripheral Atherectomy Procedure Volumes
- Market Drivers & Limiters for Each Market Segment
- Market Forecasts Until 2027, and Historical Data to 2017
- COVID19 Impact on the Global Atherectomy Market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY PROCEDURE VOLUMES
In our comprehensive study on the global atherectomy devices market, the publisher has conducted an in-depth analysis of atherectomy and Intravascular lithotripsy procedure volumes. This analysis aims to enhance the accuracy of our market sizing and provide you with valuable insights into the volume of procedures conducted over a 10-year period across 70 countries.ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY MARKET INSIGHTS
Coronary atherectomy procedures are typically conducted after the identification of artery calcification through an angioplasty or other diagnostic procedure. While coronary physicians may not consider atherectomy as their primary choice, the number of atherectomy procedures is anticipated to rise in conjunction with the increasing utilization of angioplasty procedures.The market for coronary atherectomy is expected to be limited by the efficacy of drug-eluting stents (DESs). The use of DESs provides cardiologists with a sense of confidence in preventing restenosis, potentially leading them to be less cautious in preparing the lesion before stent deployment. As the utilization of DESs becomes more prevalent in coronary procedures, the demand for atherectomy devices is likely to decline.
ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY MARKET SHARE INSIGHTS
The global market for atherectomy and intravascular lithotripsy devices in 2022 was dominated by three key competitors: ShockWave Medical, Boston Scientific, and Cardiovascular Systems, Inc.ShockWave Medical, as the leading competitor, specializes in IVL technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. Their device, ShockWave C2, has established a strong market presence.
Boston Scientific, the second-leading competitor, focuses on the mechanical atherectomy device market. While they continue to maintain competitiveness in this segment, they have experienced a decline in market share in recent years.
Cardiovascular Systems, Inc. (CSI) held the third-leading position in the coronary atherectomy device market. Their presence in the overall market was primarily attributed to their involvement in the mechanical atherectomy device segment, where they held a significant share.
Overall, these three competitors played a crucial role in shaping the atherectomy and IVL device market landscape in 2022.
RESEARCH REGIONAL COVERAGE
Throughout our comprehensive research series, the author has extensively covered and analyzed over 70 countries worldwide. Each global region can be purchased as an individual report, allowing you to tailor the data specifically to your needs. The regions covered in our research include:- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Georgia, Slovakia, Slovenia, Azerbaijan, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), Serbia and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Table of Contents
Atherectomy and Intravascular Lithotripsy Device Market
List of Charts
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avinger
- Boston Scientific
- Cardiovascular Systems Inc.
- ShockWave Medical
- Philips
